Arthritis News and Research

Latest Arthritis News and Research

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

EntreMed has announced the issuance of U.S. Patent No. 7,012,070 covering methods of treatment for a broad range of indications with its lead clinical-stage compound, 2-methoxyestradiol (2ME2).

17 Mar 2006

Drug trial nightmare - two still critically ill

In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.

17 Mar 2006

Drug trial goes wrong and six end up intensive care

After taking part in a clinical trial of a new drug six men are now seriously ill in a north London hospital in the UK.

15 Mar 2006

RvE1 protects from inflammation and bone loss in experimental periodontitis

Gum disease is initiated by bacteria populating dental plaque and may eventually result in tissue and tooth loss.

13 Mar 2006

Rheumatoid arthritis does not increase risk of hearing loss

Mayo Clinic researchers have found that people with rheumatoid arthritis are no more likely to have hearing loss than other members of the general population.

9 Mar 2006

UCB submits application to FDA for new treatment in Crohn's disease

UCB has announced the submission of a Biologics License Application (BLA) to the United States Food and Drug Administration (FDA) for the approval of CIMZIA (certolizumab pegol, CDP870) for the treatment of patients with Crohn's disease.

6 Mar 2006

FDA approves Rituxan (Rituximab)

Rituxan is the first treatment for RA that selectively targets immune cells known as CD20-positive B-cells. Through this unique mechanism of action, Rituxan may affect multiple pathways by which B-cells are believed to contribute to the initiation and development of RA.

1 Mar 2006

Link between rheumatoid arthritis and cancer examined

Rheumatoid arthritis is an inflammatory disease of the immune system and is thought to be linked to an increased risk of cancers of the lymphatic system.

28 Feb 2006

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

A second course of methotrexate, the most commonly used drug to treat rheumatoid arthritis, is effective in nearly half of studied patients for whom a previous treatment with the drug was ineffective.

27 Feb 2006

New generation gold-based drugs for treating rheumatoid arthritis

Gold compounds have been used for the treatment of rheumatoid arthritis and other autoimmune diseases for more than 75 years, but until now, how the metals work has been a mystery.

27 Feb 2006

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

An inflammatory disease of the immune system, rheumatoid arthritis (RA) is associated with increased occurrence of lymphoma--or cancers of the lymphatic system, which plays an integral role in the body's ability to fight infection.

27 Feb 2006

Study associates meniscal damage with advanced cartilage loss in early osteoarthritis

Cartilage loss is a major component of osteoarthritis (OA), a joint disease that affects over 20 million Americans. In knee OA, cartilage loss is influenced by knee injury, as well as obesity and age. Every healthy knee is supported and protected by a pair of meniscus.

27 Feb 2006

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

Offering hope for millions of people who suffer the most from osteoarthritis, a study published in the New England Journal of Medicine (NEJM) has found that the combined use of two dietary supplements - glucosamine and chondroitin - provided significant pain relief from the most common form of arthritis.

24 Feb 2006

Arthritis News and Research

Latest Arthritis News and Research

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

Drug trial nightmare - two still critically ill

Drug trial goes wrong and six end up intensive care

RvE1 protects from inflammation and bone loss in experimental periodontitis

Rheumatoid arthritis does not increase risk of hearing loss

UCB submits application to FDA for new treatment in Crohn's disease

FDA approves Rituxan (Rituximab)

Link between rheumatoid arthritis and cancer examined

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

New generation gold-based drugs for treating rheumatoid arthritis

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Study associates meniscal damage with advanced cartilage loss in early osteoarthritis

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

New report suggests promising strategies to preserve brain health as people grow older

Efficacy of glucosamine, chondroitin sulfate may depend on level of osteoarthritis pain

Glucosamine/Chondroitin combo helps those with moderate to severe joint pain

Selective T cell stimulation could help improve treatment of autoimmune disease and cancer

Breakthrough anti-inflammatory treatment

Radiologists more accurately identify damage to knee cartilage by using four radiologic 'signs'

Protein levels predict bone marrow transplant survival

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Arthritis News and Research

Latest Arthritis News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in